Haemonetics Corporation (HAE)
Healthcare • Medical Devices
StockNYSEUnited StatesUS4050241003
122.72 USD
+1.81% today Updated 12 Nov 2026 21:05
Kyvero is an independent information site. It is not affiliated with, endorsed by or sponsored by Haemonetics Corporation, and has no access to any account you may have with it. The name and the logo belong to their owners.
Price history
Daily prices in USD. Dividends, results and news are marked on the day they happened; click a day to see them.
Updated 12 Nov 2026 21:05. Information, not advice. Showing the last 12 months. Create a free account to see the whole history
Results
Next results
04 Feb 2027
in 83 days · 08:00 · estimate 1.27
Last results
1.35 vs 1.29 estimated
05 Nov 2026 · Beat +4.6%
Beat the estimate
11 of 12
0 missed · 1 in line · 10 beats in a row
Average surprise
+5.0%
reported against the estimate, last 12 quarters
Earnings per share: estimate and reported
Estimate Reported: beat Reported: miss In line
Quarterly results
| Date | EPS estimate | EPS reported | Surprise | Result |
|---|---|---|---|---|
| 04 Feb 2027 08:00 | 1.27 | — | — | Upcoming |
| 05 Nov 2026 06:00 | 1.29 | 1.35 | +4.6% | Beat |
| 06 Aug 2026 06:00 | 1.08 | 1.14 | +5.9% | Beat |
| 07 May 2026 06:00 | 1.27 | 1.29 | +1.4% | Beat |
| 05 Feb 2026 06:00 | 1.25 | 1.31 | +4.8% | Beat |
| 06 Nov 2025 06:00 | 1.11 | 1.27 | +14.4% | Beat |
| 07 Aug 2025 06:00 | 1.02 | 1.10 | +8.3% | Beat |
| 08 May 2025 06:00 | 1.22 | 1.24 | +1.6% | Beat |
| 06 Feb 2025 06:00 | 1.17 | 1.19 | +1.7% | Beat |
| 07 Nov 2024 06:00 | 1.07 | 1.12 | +4.4% | Beat |
| 08 Aug 2024 06:00 | 1.01 | 1.02 | +1.4% | Beat |
| 09 May 2024 06:00 | 0.89 | 0.90 | +0.9% | In line |
| 08 Feb 2024 06:00 | 0.94 | 1.04 | +10.5% | Beat |
| 02 Nov 2023 06:00 | 0.89 | 0.99 | +11.5% | Beat |
| 08 Aug 2023 06:00 | 0.73 | 1.05 | +44.2% | Beat |
| 11 May 2023 06:00 | 0.70 | 0.77 | +9.3% | Beat |
| 07 Feb 2023 06:00 | 0.82 | 0.85 | +4.1% | Beat |
| 07 Nov 2022 06:00 | 0.67 | 0.83 | +23.2% | Beat |
| 10 Aug 2022 06:00 | 0.51 | 0.58 | +13.7% | Beat |
| 10 May 2022 06:00 | 0.60 | 0.65 | +8.3% | Beat |
| 08 Feb 2022 06:00 | 0.73 | 0.84 | +14.5% | Beat |
| 09 Nov 2021 06:00 | 0.61 | 0.60 | -1.0% | In line |
| 11 Aug 2021 06:00 | 0.45 | 0.50 | +11.1% | Beat |
| 13 May 2021 06:00 | 0.67 | 0.46 | -31.5% | Miss |
| 02 Feb 2021 06:00 | 0.65 | 0.81 | +23.8% | Beat |
| 04 Nov 2020 06:00 | 0.51 | 0.62 | +22.6% | Beat |
| 04 Aug 2020 06:00 | 0.41 | 0.46 | +11.0% | Beat |
| 05 May 2020 06:00 | 0.73 | 0.69 | -5.3% | Miss |
| 04 Feb 2020 16:00 | 0.76 | 0.94 | +24.2% | Beat |
| 01 Nov 2019 16:00 | 0.72 | 0.87 | +20.8% | Beat |
| 06 Aug 2019 16:00 | 0.64 | 0.81 | +27.4% | Beat |
| 07 May 2019 06:00 | 0.55 | 0.61 | +10.6% | Beat |
| 05 Feb 2019 06:00 | 0.59 | 0.63 | +6.5% | Beat |
| 06 Nov 2018 06:00 | 0.54 | 0.56 | +3.4% | Beat |
| 07 Aug 2018 06:00 | 0.42 | 0.59 | +42.2% | Beat |
| 08 May 2018 06:00 | 0.43 | 0.43 | +0.7% | In line |
| 06 Feb 2018 06:00 | 0.44 | 0.62 | +42.3% | Beat |
| 07 Nov 2017 06:00 | 0.41 | 0.48 | +16.3% | Beat |
| 07 Aug 2017 06:00 | 0.30 | 0.33 | +9.4% | Beat |
| 08 May 2017 01:00 | 0.38 | 0.39 | +4.0% | Beat |
| 06 Feb 2017 01:00 | 0.40 | 0.43 | +6.6% | Beat |
| 07 Nov 2016 16:00 | 0.35 | 0.46 | +29.8% | Beat |
| 01 Aug 2016 06:00 | 0.29 | 0.25 | -13.4% | Miss |
| 02 May 2016 06:00 | 0.46 | 0.37 | -19.7% | Miss |
| 01 Feb 2016 06:00 | 0.45 | 0.48 | +5.6% | Beat |
| 04 Nov 2015 06:00 | 0.40 | 0.44 | +9.6% | Beat |
| 27 Jul 2015 06:00 | 0.31 | 0.35 | +11.3% | Beat |
| 27 Apr 2015 06:00 | 0.52 | 0.47 | -10.2% | Miss |
| 29 Jan 2015 08:00 | 0.51 | 0.53 | +4.8% | Beat |
| 03 Nov 2014 06:00 | 0.45 | 0.47 | +3.4% | Beat |
Annual results · USD
| Year | Revenue | Change | Net income | Net margin | EPS | EPS change | Free cash flow |
|---|---|---|---|---|---|---|---|
| 2026 | 1.3B | -2.0% | 97.3M | 7.3% | 2.05 | -38.1% | 260.4M |
| 2025 | 1.4B | +4.0% | 167.7M | 12.3% | 3.31 | +44.5% | 142.4M |
| 2024 | 1.3B | +12.0% | 117.6M | 9.0% | 2.29 | +2.2% | 143.6M |
| 2023 | 1.2B | — | 115.4M | 9.9% | 2.24 | — | 81.7M |
Dates and earnings per share from the company reports as collected by the data provider; the estimate is the analysts' average before the report. Information, not advice.
Prices by day, week and month
| Period | Opening price | High | Low | Closing price | Change | Volume | Dividend |
|---|---|---|---|---|---|---|---|
| 12 Nov 2026 | 120.78 | 124.00 | 119.45 | 122.72 | +1.81% | 455,370 | |
| 11 Nov 2026 | 123.09 | 123.18 | 120.02 | 120.54 | -1.49% | 390,200 | |
| 10 Nov 2026 | 117.90 | 123.08 | 116.68 | 122.36 | +3.51% | 797,900 | |
| 09 Nov 2026 | 121.16 | 122.97 | 117.48 | 118.21 | -1.43% | 999,300 | |
| 06 Nov 2026 | 121.16 | 123.75 | 116.79 | 119.93 | -3.37% | 834,700 | |
| 05 Nov 2026 | 126.06 | 132.00 | 121.22 | 124.11 | -2.60% | 1,302,100 | |
| 04 Nov 2026 | 122.16 | 128.83 | 121.26 | 127.42 | +5.94% | 981,900 | |
| 03 Nov 2026 | 119.07 | 121.44 | 119.00 | 120.28 | +0.12% | 832,000 | |
| 02 Nov 2026 | 120.36 | 121.49 | 119.08 | 120.14 | +0.41% | 678,600 | |
| 30 Oct 2026 | 120.50 | 120.50 | 118.40 | 119.65 | -0.12% | 453,300 | |
| 1,254 older periods: create a free account to see the whole history | |||||||
Prices in USD, adjusted for splits but not for dividends. Weeks run Monday to Friday and months follow the calendar; the change compares each close with the previous period's. Dividends are those whose ex-dividend date falls in the period, per share. Information, not advice.
News
- HAE Q3 CY2026 deep dive: plasma growth and new product launches drive momentum (opens in a new tab) StockStory · 10 Nov 2026 12:37
- International Markets and Haemonetics (HAE): A Deep Dive for Investors (opens in a new tab) Zacks · 09 Nov 2026 13:15
- Should Raised Revenue Outlook Require Action From Haemonetics Stock Investors? (opens in a new tab) Simply Wall St. · 08 Nov 2026 02:13
- Haemonetics (HAE) Stock May Be 34% Undervalued On Cash Flow (opens in a new tab) Simply Wall St. · 07 Nov 2026 15:13
- Haemonetics Q2 Earnings Call Highlights (opens in a new tab) MarketBeat · 07 Nov 2026 14:15
- Haemonetics (HAE) Beats Q2 Expectations, Is The Stock Still Cheap? (opens in a new tab) Simply Wall St. · 07 Nov 2026 11:09
- Citigroup Maintains Buy on Haemonetics, Raises Price Target to $149 (opens in a new tab) Benzinga · 06 Nov 2026 17:48
- Barrington Research Maintains Outperform on Haemonetics, Raises Price Target to $145 (opens in a new tab) Benzinga · 06 Nov 2026 16:05
- Haemonetics Corp (HAE) (Q2 2027) Earnings Call Highlights: Raised Guidance and Expanded CSL ... (opens in a new tab) GuruFocus.com · 06 Nov 2026 09:12
- Haemonetics Corporation Q2 2027 Earnings Call Summary (opens in a new tab) Moby · 05 Nov 2026 23:43
- Haemonetics (HAE) Q2 2027 Earnings Call Transcript (opens in a new tab) Motley Fool · 05 Nov 2026 20:45
- Haemonetics Corporation 2027 Q2 - Results - Earnings Call Presentation (opens in a new tab) SeekingAlpha · 05 Nov 2026 15:01
- BTIG Maintains Buy on Haemonetics, Raises Price Target to $142 (opens in a new tab) Benzinga · 05 Nov 2026 13:34
- Haemonetics Corporation (HAE) Hits Fresh High: Is There Still Room to Run? (opens in a new tab) Zacks · 05 Nov 2026 13:15
- Haemonetics Corporation (HAE) Q2 2027 Earnings Call Transcript (opens in a new tab) SeekingAlpha · 05 Nov 2026 13:14
Headlines link to the original articles of the publishers shown; Kyvero does not write, check or endorse them. Only the most relevant news about each company is kept. Information, not advice.
Key data
- Previous close
- 120.54 USD
- Market cap
- 5.6B
- Exchange
- NYSE
- Country
- United States
- Sector
- Healthcare
- Industry
- Medical Devices
- Currency
- USD
Dividends
No dividends on record.
Why this score
Similar shares
Follow HAE and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.